Article

jdsupra.com on 2023-03-17 21:54

OIG Greenlights Manufacturer’s Limited Free Drug Program

On February 28, 2023, the Office of Inspector General (“OIG”) issued Advisory Opinion No. 23-02 (“Opinion”), which favorably addresses a ...

United States

Related news

OIG Issues Advisory Opinion Giving the Green Light to a Pharmaceutical Manufacturer’s Plan to Provide Limited Functionality Smartphones to Financially Needy Patients for Adherence Data Monitoring jdsupra.com
California , Switzerland , Spalding , United States
OIG Greenlights Digital Health Program Offering Free Smartphones to Patients jdsupra.com
California , United States , Switzerland
HHS-OIG: Pharma Manufacturer’s Proposed Copayment Assistance Program ‘Highly Suspect’ Under Federal Anti-Kickback Statute jdsupra.com
Reg , United States
OIG Advisory Opinion Rejects Pharmaceutical Manufacturer’s Proposed Beneficiary Cost-Sharing Program jdsupra.com
Reg , United States
OIG Approves Limited, Free Drug Program jdsupra.com
OIG Determines a Drug Manufacturer’s Initiative to Cover Certain Patients’ Transportation Costs Poses Low Risk of Fraud and Abuse jdsupra.com
Poses
Blog: OIG Provides Strong Rebuke of Pharmaceutical Free Drug Program jdsupra.com
California , United States , Switzerland
OIG Issues Favorable Opinion for Pharmaceutical Manufacturer's Free Drug Program jdsupra.com
Reg
OIG Approves a Free Drug Program Limited to Hospital Inpatients jdsupra.com
OIG Approves Free Drug Program for Ultra-Rare Condition in Advisory Opinion 23-02 jdsupra.com
United States
OIG Issues Advisory Opinion Permitting Drug Manufacturer to Provide Travel, Lodging, and Expenses to Patients in Limited Circumstances jdsupra.com
California , United States , Switzerland , Spalding
OIG Issues Favorable Advisory Opinion (No. 21-01) on Free Drug Program jdsupra.com
OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
California , United States , Switzerland
OIG Issues Advisory Opinion for Pharmaceutical Manufacturer’s Cost-Sharing Assistance Proposal jdsupra.com
OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trial jdsupra.com
OIG allows drug company to provide free medication during coverage determination delay jdsupra.com
United States
OIG Approves Free Post-Discharge Care Program jdsupra.com
California , United States , Switzerland
OIG General Compliance Program Guidance November 2023 jdsupra.com
Reg , United States
OIG Approves Charitable Organization's Patient Assistance Program jdsupra.com
COVID-19 vaccine monitoring program limited to English speakers The Verge
United States , Vietnam , China , Spain , United Kingdom